3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is ever more attracting researcher attention due to sparse information suggesting different physiological properties. Present studies demonstrate that 3-HPC may exhibit distinct impacts on the central system, possibly contributing to some of the unanticipated symptoms linked with